TCL Archive Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen November 17, 1989
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Groups Lobby Congress For $5.8 Billion Budget For NCI, Increases For Other Programs June 18, 2010
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
